{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:41:57Z","timestamp":1783460517448,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"OsloMet - Oslo Metropolitan University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine is a prevalent neurological disorder and a leading cause of disability worldwide. Despite effective medications, many patients experience underdiagnosis, suboptimal medication use, and poor adherence. Pharmacists are well-positioned to provide medication counselling, yet their role in structured migraine counselling services within community pharmacy practice remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This pilot study explored pharmacists\u2019 experiences and patient-reported consultation outcomes associated with a pharmacist-led migraine consultation service in community pharmacies, with the aim of generating exploratory evidence to inform future implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed-methods prospective pilot service evaluation was conducted, and findings were interpreted using an implementation science perspective. Pharmacists from 19 Norwegian community pharmacies received targeted training and conducted structured migraine consultations between May 2023 and January 2024. Each patient was offered two consultations. In total, 198 first consultations and 44 follow-up consultations were completed. Semi-structured pharmacist interviews were analysed qualitatively, and patient-reported motivation for and experiences with the consultations, use of recommendations, and changes in frequency and\/or severity of migraine attacks were assessed using self-reported and pharmacist-reported questionnaires. Chi-square tests and Wilcoxon signed-rank tests were used to explore differences between observations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pharmacists reported that migraine consultations were perceived by pharmacists as implementable within pharmacy practice, professionally valuable, and strengthened their role in primary healthcare. Time constraints and funding were noted as barriers. Overall patients reported positive consultation experiences (adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.011). Among patients returning for follow-up consultations, 69% reported having implemented at least one recommendation from the pharmacist at the first consultation, and 38% reported perceived improvement in migraine status. Participants who reported implementing recommendations tended to report fewer and\/or less severe migraine attacks; however, this difference did not reach statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.085). Motivation for medication use was high both before and after the consultations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pilot service evaluation suggests that pharmacist-led migraine counselling may represent a clinically relevant and potentially useful addition to community pharmacy practice. Responding patients reported positive consultation experiences and reported to be highly motivated to take their medication. The majority implemented at least one recommendation, and many reported perceived improvements in migraine status. However, limited follow-up data indicates that findings should be interpreted cautiously. Larger-scale studies with validated instruments are needed to assess long-term effects and implementation models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-026-02374-3","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:53:51Z","timestamp":1777463631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacist-led migraine consultations in community pharmacies: a pilot study of pharmacists\u2019 experiences and patient-reported outcomes"],"prefix":"10.1186","volume":"27","author":[{"given":"Lene Berge","family":"Holm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Gazerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Krogstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2374_CR1","doi-asserted-by":"publisher","first-page":"800605","DOI":"10.3389\/fneur.2021.800605","volume":"12","author":"P Amiri","year":"2021","unstructured":"Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S (2021) Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol 12:800605. https:\/\/doi.org\/10.3389\/fneur.2021.800605","journal-title":"Front Neurol"},{"issue":"8","key":"2374_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lant\u00e9ri-Minet M, Braschinsky M, Del Rio MS, Daniel O, \u00d6zge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Ashina M (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514. https:\/\/doi.org\/10.1038\/s41582-021-00509-5","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2374_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/head.12353","volume":"54","author":"RR Ramsey","year":"2014","unstructured":"Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA (2014) Treatment adherence in patients with headache: a systematic review. Headache 54(5):795\u2013816. https:\/\/doi.org\/10.1111\/head.12353","journal-title":"Headache"},{"issue":"2","key":"2374_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40267-020-00801-2","volume":"37","author":"N Patel","year":"2021","unstructured":"Patel N, Barnhart R, Konkol P, Varda J, Nelson R, Smith T (2021) Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists. Drugs Therapy Perspect 37(2):75\u201386. https:\/\/doi.org\/10.1007\/s40267-020-00801-2","journal-title":"Drugs Therapy Perspect"},{"key":"2374_CR5","doi-asserted-by":"publisher","unstructured":"Ljubisavljevic S, Ljubisavljevic M, Damjanovic R, Kalinic S (2023) A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities. Brain Sci 13(10). https:\/\/doi.org\/10.3390\/brainsci13101408","DOI":"10.3390\/brainsci13101408"},{"issue":"6","key":"2374_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0333102414547138","volume":"35","author":"Z Hepp","year":"2015","unstructured":"Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB (2015) Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 35(6):478\u2013488. https:\/\/doi.org\/10.1177\/0333102414547138","journal-title":"Cephalalgia"},{"key":"2374_CR7","doi-asserted-by":"publisher","unstructured":"Kvarnstr\u00f6m K, Westerholm A, Airaksinen M, Liira H (2021) Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics 13(7). https:\/\/doi.org\/10.3390\/pharmaceutics13071100","DOI":"10.3390\/pharmaceutics13071100"},{"issue":"1","key":"2374_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s10194-025-02107-y","volume":"26","author":"A Elmazny","year":"2025","unstructured":"Elmazny A, Magdy R, Hussein M, Ismaeel AY, Essmat A, Elbeltagy KE, Hussein SMM, Hassan NS, Elbehiry NM, Osama W, Abdelazeem HN, Elshebawy H (2025) Migraine triggers and lifestyle modifications: an assessment of patients\u2019 awareness and the role of healthcare providers in patient education. J Headache Pain 26(1):189. https:\/\/doi.org\/10.1186\/s10194-025-02107-y","journal-title":"J Headache Pain"},{"issue":"1","key":"2374_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-019-1038-4","volume":"20","author":"EC Agostoni","year":"2019","unstructured":"Agostoni EC, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F, Geppetti P, Grazzi L, Leone M, Martelletti P, Pini LA, Prudenzano MP, Sarchielli P, Tedeschi G, Russo A (2019) Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain 20(1):92. https:\/\/doi.org\/10.1186\/s10194-019-1038-4","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"2374_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10072-014-1732-6","volume":"35","author":"M Giaccone","year":"2014","unstructured":"Giaccone M, Baratta F, Allais G, Brusa P (2014) Prevention, education and information: the role of the community pharmacist in the management of headaches. Neurol Sci 35(Suppl 1):1\u20134. https:\/\/doi.org\/10.1007\/s10072-014-1732-6","journal-title":"Neurol Sci"},{"key":"2374_CR11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2147\/ppa.S530503","volume":"19","author":"L Farhana","year":"2025","unstructured":"Farhana L, Rahayu FP, Sholihah S, Sweileh W, Abdulah R, Alfian SD (2025) Effectiveness of Pharmacist-Led Intervention on Medication Adherence in Chronic Diseases: A Systematic Review of Randomized Controlled Trials. Patient Prefer Adherence 19:2161\u20132178. https:\/\/doi.org\/10.2147\/ppa.S530503","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"2374_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s10194-025-02073-5","volume":"26","author":"H BaniHani","year":"2025","unstructured":"BaniHani H, Lampl C, MaassenvandenBrink A, Amin FM, Carlsen LN, Coppola G, Deligianni C, Gil-Gouveia R, Holland PR, Hus\u00f8y AK, Jensen R, Pl\u00e1cido M, Reuter U, Ryli\u0161kien\u0117 K, Del R\u00edo MS, Schytz HW, Tronvik E, Versijpt J, Steiner TJ (2025) Correction: The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical federation. J Headache Pain 26(1):139. https:\/\/doi.org\/10.1186\/s10194-025-02073-5","journal-title":"J Headache Pain"},{"key":"2374_CR13","doi-asserted-by":"publisher","unstructured":"Alfahmi AS, Alqarni LA, Alkhatabi LA, Alshehri FS (2025) Pharmacists\u2019 Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study. Healthc (Basel) 13(17). https:\/\/doi.org\/10.3390\/healthcare13172231","DOI":"10.3390\/healthcare13172231"},{"key":"2374_CR14","doi-asserted-by":"publisher","unstructured":"Robertson J (2025) Upskilling pharmacy teams to make migraine care routine practice. Pharm J 315(8000). https:\/\/doi.org\/10.1211\/PJ.2025.1.369010","DOI":"10.1211\/PJ.2025.1.369010"},{"issue":"2","key":"2374_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M (2011) Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health Mar 38(2):65\u201376. https:\/\/doi.org\/10.1007\/s10488-010-0319-7PMID: 20957426; PMCID: PMC3068522","journal-title":"Adm Policy Ment Health Mar"},{"key":"2374_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13012-021-01181-5","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist O, M. A. et al (2022) Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum. Implement Sci 17:7. https:\/\/doi.org\/10.1186\/s13012-021-01181-5","journal-title":"Implement Sci"},{"issue":"4","key":"2374_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2374_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"issue":"8","key":"2374_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/1403494812465030","volume":"40","author":"K Malterud","year":"2012","unstructured":"Malterud K (2012) Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health 40(8):795\u2013805. https:\/\/doi.org\/10.1177\/1403494812465030","journal-title":"Scand J Public Health"},{"key":"2374_CR20","doi-asserted-by":"publisher","first-page":"1194134","DOI":"10.3389\/fpain.2023.1194134","volume":"4","author":"YT Kebede","year":"2023","unstructured":"Kebede YT, Mohammed BD, Tamene BA, Abebe AT, Dhugasa RW (2023) Medication overuse headache: a review of current evidence and management strategies. Front Pain Res (Lausanne) 4:1194134. https:\/\/doi.org\/10.3389\/fpain.2023.1194134","journal-title":"Front Pain Res (Lausanne)"},{"issue":"3","key":"2374_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J (2011) Patient medication adherence: measures in daily practice. Oman Med J 26(3):155\u2013159. https:\/\/doi.org\/10.5001\/omj.2011.38","journal-title":"Oman Med J"},{"issue":"5","key":"2374_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/ijpp.12462","volume":"26","author":"A Milosavljevic","year":"2018","unstructured":"Milosavljevic A, Aspden T, Harrison J (2018) Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: a systematic review. Int J Pharm Pract 26(5):387\u2013397. https:\/\/doi.org\/10.1111\/ijpp.12462","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"2374_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-024-01755-w","volume":"25","author":"H Gosalia","year":"2024","unstructured":"Gosalia H, Moreno-Ajona D, Goadsby PJ (2024) Medication-overuse headache: a narrative review. J Headache Pain 25(1):89. https:\/\/doi.org\/10.1186\/s10194-024-01755-w","journal-title":"J Headache Pain"},{"issue":"1","key":"2374_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12883-021-02451-x","volume":"21","author":"AM Deighton","year":"2021","unstructured":"Deighton AM, Harris LA, Johnston K, Hogan S, Quaranta LA, L\u2019Italien G, Coric V (2021) The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review. BMC Neurol 21(1):425. https:\/\/doi.org\/10.1186\/s12883-021-02451-x","journal-title":"BMC Neurol"},{"key":"2374_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/iprp.S248699","volume":"10","author":"L Murphy","year":"2021","unstructured":"Murphy L, Ng K, Isaac P, Swidrovich J, Zhang M, Sproule BA (2021) The Role of the Pharmacist in the Care of Patients with Chronic Pain. Integr Pharm Res Pract 10:33\u201341. https:\/\/doi.org\/10.2147\/iprp.S248699","journal-title":"Integr Pharm Res Pract"},{"issue":"1","key":"2374_CR26","doi-asserted-by":"publisher","first-page":"2487046","DOI":"10.1080\/20523211.2025.2487046","volume":"18","author":"M Petrides","year":"2025","unstructured":"Petrides M, Peletidi A, Nena E, Constantinidis T, Kontogiorgis C (2025) The role of pharmacists in enhancing epilepsy care: a systematic review of community and outpatient interventions. J Pharm Policy Pract 18(1):2487046. https:\/\/doi.org\/10.1080\/20523211.2025.2487046","journal-title":"J Pharm Policy Pract"},{"issue":"5","key":"2374_CR27","first-page":"29","volume":"47","author":"YC Terrie","year":"2022","unstructured":"Terrie YC (2022) The Pharmacist\u2019s Role in Educating Patients About Depression. US Pharmacist 47(5):29\u201333","journal-title":"US Pharmacist"},{"issue":"3","key":"2374_CR28","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.lanprc.2025.100027","volume":"1","author":"LN Allen","year":"2025","unstructured":"Allen LN, Rasanathan K, Mash R, Uribe MV, Martinez-Bianchi V, Kidd M (2025) Models of global primary care post-2030. Lancet Prim Care 1(3):100027. https:\/\/doi.org\/10.1016\/j.lanprc.2025.100027","journal-title":"Lancet Prim Care"},{"issue":"7","key":"2374_CR29","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C (2020) The Medication Adherence Report Scale: A measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol 86(7):1281\u20131288. https:\/\/doi.org\/10.1111\/bcp.14193","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02374-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:41Z","timestamp":1781650541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02374-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted to evaluate a pharmacist-led counselling service for potential future implementation within routine community pharmacy practice. The study received ethical approval from the Norwegian Agency for Shared Services in Education and Research (SIKT, reference number 929017). All participants were informed about the study objectives, confidentiality procedures, and their right to withdraw at any stage without consequences. Written informed consent was obtained from all participants prior to data collection. All data were anonymized and stored securely in compliance with institutional policies and the General Data Protection Regulation (GDPR). No financial incentives were provided to pharmacists or patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}